Erbilgin, Y. Et Al. 2019. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. LEUKEMIA & LYMPHOMA , vol.60 , 200-207.

Erbilgin, Y., Eskazan, A. E., Ng, O. H., Salihoglu, A., Elverdi, T., Firtina, S., ... Tasar, O.(2019). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. LEUKEMIA & LYMPHOMA , vol.60, 200-207.

Erbilgin, Yücel Et Al. "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors," LEUKEMIA & LYMPHOMA , vol.60, 200-207, 2019

Erbilgin, Yücel Et Al. "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors." LEUKEMIA & LYMPHOMA , vol.60, pp.200-207, 2019

Erbilgin, Y. Et Al. (2019) . "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors." LEUKEMIA & LYMPHOMA , vol.60, pp.200-207.

@article{article, author={Yücel ERBİLGİN Et Al. }, title={Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors}, journal={LEUKEMIA & LYMPHOMA}, year=2019, pages={200-207} }